JP2000516911A5 - - Google Patents

Download PDF

Info

Publication number
JP2000516911A5
JP2000516911A5 JP1997534640A JP53464097A JP2000516911A5 JP 2000516911 A5 JP2000516911 A5 JP 2000516911A5 JP 1997534640 A JP1997534640 A JP 1997534640A JP 53464097 A JP53464097 A JP 53464097A JP 2000516911 A5 JP2000516911 A5 JP 2000516911A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997534640A
Other languages
English (en)
Other versions
JP2000516911A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/005032 external-priority patent/WO1997035619A1/en
Publication of JP2000516911A publication Critical patent/JP2000516911A/ja
Publication of JP2000516911A5 publication Critical patent/JP2000516911A5/ja
Ceased legal-status Critical Current

Links

Description

Figure 2000516911
Figure 2000516911
Figure 2000516911
Figure 2000516911
Figure 2000516911
Figure 2000516911
Figure 2000516911
Figure 2000516911
Figure 2000516911
Figure 2000516911
Figure 2000516911
Figure 2000516911
Figure 2000516911
Figure 2000516911
Figure 2000516911
JP53464097A 1996-03-28 1997-03-27 オプソニン強化細胞、および抗原に対する免疫応答を調節する方法 Ceased JP2000516911A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1436496P 1996-03-28 1996-03-28
US60/014,364 1996-03-28
PCT/US1997/005032 WO1997035619A1 (en) 1996-03-28 1997-03-27 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2004094676A Division JP4754784B2 (ja) 1996-03-28 2004-03-29 オプソニン強化細胞、および抗原に対する免疫応答を調節する方法

Publications (2)

Publication Number Publication Date
JP2000516911A JP2000516911A (ja) 2000-12-19
JP2000516911A5 true JP2000516911A5 (ja) 2004-12-02

Family

ID=21765050

Family Applications (2)

Application Number Title Priority Date Filing Date
JP53464097A Ceased JP2000516911A (ja) 1996-03-28 1997-03-27 オプソニン強化細胞、および抗原に対する免疫応答を調節する方法
JP2004094676A Expired - Fee Related JP4754784B2 (ja) 1996-03-28 2004-03-29 オプソニン強化細胞、および抗原に対する免疫応答を調節する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2004094676A Expired - Fee Related JP4754784B2 (ja) 1996-03-28 2004-03-29 オプソニン強化細胞、および抗原に対する免疫応答を調節する方法

Country Status (7)

Country Link
US (2) US5951976A (ja)
EP (1) EP0921816A4 (ja)
JP (2) JP2000516911A (ja)
AU (1) AU734196B2 (ja)
BR (1) BR9708387A (ja)
CA (1) CA2249354A1 (ja)
WO (1) WO1997035619A1 (ja)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2224273T3 (es) 1996-09-30 2005-03-01 University Of Arkansas Metodo para producir inmunidad activa por medio de un conjugado de vacuna.
WO1999010001A1 (fr) * 1997-08-21 1999-03-04 Takara Shuzo Co., Ltd. Agents cancerostatiques
EP2295065B1 (en) * 1998-02-20 2013-10-09 The University of Miami Modified heat shock protein-antigenic peptide complex
DE69940731D1 (de) * 1998-05-26 2009-05-28 Genitrix Llc Zusammensetzungen und verfahren zur modulation einer immunantwort auf ein antigen durch verabreichung von zytokine-beladenen zellen
US7030211B1 (en) * 1998-07-08 2006-04-18 Gemvax As Antigenic peptides derived from telomerase
US6884785B2 (en) * 1999-06-17 2005-04-26 The Scripps Research Institute Compositions and methods for the treatment or prevention of autoimmune diabetes
US7015204B1 (en) * 1999-10-07 2006-03-21 Cornell Research Foundation, Inc. Protective immunity or immunological tolerance induced with RNA particularly total cellular RNA
US8128922B2 (en) 1999-10-20 2012-03-06 Johns Hopkins University Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
GB9930591D0 (en) * 1999-12-23 2000-02-16 Univ London Component for vaccine
JP5087201B2 (ja) * 2000-08-03 2012-12-05 ジョンズ・ホプキンス・ユニバーシティ 抗原に小胞体シャペロンポリペプチドを連結した分子ワクチン
WO2002041913A1 (en) * 2000-11-27 2002-05-30 Jens Christian Jensenius Collectins as adjuvants
US7507724B2 (en) 2001-01-16 2009-03-24 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
AU2002350409A1 (en) * 2001-10-26 2003-05-06 Uffe Holmskov Surfactant protein-d and atherosclerosis
WO2004006837A2 (en) * 2002-07-12 2004-01-22 The Johns Hopkins University Mesothelin vaccines and model systems
US9200036B2 (en) 2002-07-12 2015-12-01 The Johns Hopkins University Mesothelin vaccines and model systems
US20090110702A1 (en) 2002-07-12 2009-04-30 The Johns Hopkins University Mesothelin Vaccines and Model Systems and Control of Tumors
US7425620B2 (en) 2002-08-14 2008-09-16 Scott Koenig FcγRIIB-specific antibodies and methods of use thereof
US20040091503A1 (en) * 2002-08-20 2004-05-13 Genitrix, Llc Lectin compositions and methods for modulating an immune response to an antigen
MXPA05001953A (es) * 2002-08-20 2005-06-22 Genitrix Llc Composiciones de lecitina y metodos para modular una respuesta inmune a un antigeno.
JP4545151B2 (ja) * 2003-02-06 2010-09-15 シーラス コーポレイション 非食細胞中への侵入について減弱化されているリステリア、そのリステリアを含むワクチン、およびそれらの使用法
US7695725B2 (en) * 2003-02-06 2010-04-13 Aduro Biotech Modified free-living microbes, vaccine compositions and methods of use thereof
AU2004224425B2 (en) * 2003-02-06 2010-06-24 Aduro Biotech Modified free-living microbes, vaccine compositions and methods of use thereof
EP1644048B1 (en) * 2003-05-05 2015-04-29 Johns Hopkins University Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
GB0315991D0 (en) * 2003-07-08 2003-08-13 Dakocytomation Denmark As Standard
US7842289B2 (en) * 2003-12-24 2010-11-30 Aduro Biotech Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
WO2006073970A2 (en) * 2005-01-06 2006-07-13 The Johns Hopkins University Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
EP1846026A4 (en) * 2005-01-26 2008-07-02 Univ Johns Hopkins ANTICANCER DNA VACCINE USING PLASMID CODING ANTIGEN AND CALRETICULIN SUCH AS MUTANT ONCOPROTEINS
US20060188526A1 (en) * 2005-02-24 2006-08-24 Cunnion Kenji M Method for enhancing the immune response to Staphylococcus aureus infection
RU2420569C2 (ru) 2005-11-29 2011-06-10 Актогеникс Нв Индукция толерантности к антигенам через слизистую
PL2347775T3 (pl) 2005-12-13 2020-11-16 President And Fellows Of Harvard College Rusztowania do przeszczepiania komórek
EP1984004A4 (en) * 2006-01-17 2010-03-03 Sloan Kettering Inst Cancer THE THERAPY REINFORCING GLUCAN
CA2651962A1 (en) * 2006-05-12 2007-12-21 Oklahoma Medical Research Foundation Anthrax compositions and methods of use and production
EP2029173B1 (en) 2006-06-26 2016-07-20 MacroGenics, Inc. Fc riib-specific antibodies and methods of use thereof
WO2008024844A2 (en) * 2006-08-22 2008-02-28 The Johns Hopkins University Anticancer combination therapies
EP2774621B1 (en) 2007-01-25 2018-01-24 Intrexon Actobiotics NV Treatment of immune disease by mucosal delivery of antigens
US9085638B2 (en) 2007-03-07 2015-07-21 The Johns Hopkins University DNA vaccine enhancement with MHC class II activators
US20080260765A1 (en) * 2007-03-15 2008-10-23 Johns Hopkins University HPV DNA Vaccines and Methods of Use Thereof
WO2009039125A1 (en) * 2007-09-17 2009-03-26 The Schepens Eye Research Institute, Inc. Use of ocular neuropeptides as immune adjuvants
WO2009102465A2 (en) 2008-02-13 2009-08-20 President And Fellows Of Harvard College Continuous cell programming devices
JP2011513399A (ja) 2008-03-03 2011-04-28 ザ ユニバーシティー オブ マイアミ 同種癌細胞による免疫療法
WO2009117116A2 (en) 2008-03-20 2009-09-24 University Of Miami Heat shock protein gp96 vaccination and methods of using same
US20090285861A1 (en) * 2008-04-17 2009-11-19 Tzyy-Choou Wu Tumor cell-based cancer immunotherapeutic compositions and methods
IN2012DN06589A (ja) 2010-01-19 2015-10-23 Harvard College
JP6104806B2 (ja) 2010-10-06 2017-03-29 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 材料に基づく細胞治療のための注射可能孔形成性ハイドロゲル
JP2014523914A (ja) 2011-07-18 2014-09-18 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 操作された微生物標的化分子およびその使用
RS59898B1 (sr) 2011-10-17 2020-03-31 Massachusetts Inst Technology Intraćelijsko davanje
WO2013130875A1 (en) 2012-02-29 2013-09-06 President And Fellows Of Harvard College Rapid antibiotic susceptibility testing
LT2838515T (lt) 2012-04-16 2020-03-10 President And Fellows Of Harvard College Mezoporinės silico dioksido kompozicijos, skirtos imuninio atsako moduliavimui
EP2674167A1 (en) * 2012-06-14 2013-12-18 PLS-Design GmbH Controlled activation of complement components for use as endogenous adjuvant
EP2976642A4 (en) 2013-03-15 2016-09-21 Harvard College METHODS AND COMPOSITIONS FOR IMPROVING THE DETECTION AND / OR CAPTURE OF A TARGET ENTITY
CA2913155A1 (en) 2013-05-21 2014-11-27 President And Fellows Of Harvard College Engineered heme-binding compositions and uses thereof
JP6502940B2 (ja) 2013-08-16 2019-04-17 マサチューセッツ インスティテュート オブ テクノロジー 細胞への物質の選択的送達
EP3083658B1 (en) 2013-12-18 2019-05-08 President and Fellows of Harvard College Crp capture/detection of gram positive bacteria
JP7348708B2 (ja) 2014-04-30 2023-09-21 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 組み合わせワクチン装置および癌細胞を殺滅する方法
SG10201903912XA (en) 2014-10-31 2019-05-30 Massachusetts Inst Technology Delivery of biomolecules to immune cells
CN107002089B (zh) 2014-11-14 2021-09-07 麻省理工学院 化合物和组合物向细胞中的破坏和场实现的递送
WO2016115179A1 (en) 2015-01-12 2016-07-21 Massachusetts Institute Of Technology Gene editing through microfluidic delivery
US11786457B2 (en) 2015-01-30 2023-10-17 President And Fellows Of Harvard College Peritumoral and intratumoral materials for cancer therapy
MX2017010159A (es) 2015-02-06 2017-12-18 Heat Biologics Inc Vector que expresa conjuntamente vacunas y moléculas coestimuladoras.
EP3280464A4 (en) 2015-04-10 2018-09-26 President and Fellows of Harvard College Immune cell trapping devices and methods for making and using the same
AU2016289530B2 (en) 2015-07-09 2021-05-06 Massachusetts Institute Of Technology Delivery of materials to anucleate cells
CN108289928A (zh) 2015-08-06 2018-07-17 哈佛大学校长及研究员协会 改进的微生物-结合分子和其用途
WO2017041051A1 (en) 2015-09-04 2017-03-09 Sqz Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall
CN109072197A (zh) 2016-02-06 2018-12-21 哈佛学院校长同事会 重塑造血巢以重建免疫
WO2017143024A2 (en) 2016-02-16 2017-08-24 President And Fellows Of Harvard College Pathogen vaccines and methods of producing and using the same
WO2018013797A1 (en) 2016-07-13 2018-01-18 President And Fellows Of Harvard College Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
CA3040123A1 (en) 2016-10-11 2018-04-19 University Of Miami Vectors and vaccine cells for immunity against zika virus
WO2018187260A1 (en) 2017-04-04 2018-10-11 Heat Biologics, Inc. Intratumoral vaccination
US20200262879A1 (en) 2017-09-11 2020-08-20 Insideoutbio, Inc. Methods and compositions to enhance the immunogenicity of tumors
US20210403519A1 (en) 2018-11-02 2021-12-30 Insideoutbio, Inc. Methods and compositions to induce or suppress immune responses through the use of membrane bound complement split products

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4412990A (en) * 1982-07-02 1983-11-01 Cutter Laboratories, Inc. Composition having enhanced opsonic activity
US5270199A (en) * 1987-08-20 1993-12-14 The Children's Medical Center Corporation Human mannose-binding protein
IL89790A (en) 1988-04-01 2002-05-23 Johns Hopking University Sequences of nucleic acids encoding and cells producing CR1 protein and methods for its production and purification
US5256642A (en) 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
GB9424631D0 (en) 1994-12-06 1995-01-25 Lynxvale Ltd Modulating the immune response
US6410690B1 (en) * 1995-06-07 2002-06-25 Medarex, Inc. Therapeutic compounds comprised of anti-Fc receptor antibodies

Similar Documents

Publication Publication Date Title
JP2000502280A5 (ja)
JP2000501771A5 (ja)
JP2000501599A5 (ja)
JP2000501018A5 (ja)
JP2000500076A5 (ja)
JP2000501324A5 (ja)
JP2000516911A5 (ja)
JP2000500055A5 (ja)
JP2000500026A5 (ja)
JP2000502472A5 (ja)
JP2000501338A5 (ja)
JP2000500874A5 (ja)
JP2000502485A5 (ja)
JP2001504238A5 (ja)
JP2000502425A5 (ja)
JP2000502570A5 (ja)
JP2000502568A5 (ja)
JP2000500912A5 (ja)
JP2000501744A5 (ja)
JP2000502316A5 (ja)
JP2000500857A5 (ja)
JP2000502714A5 (ja)
JP2000501229A5 (ja)
JP2000514051A5 (ja)
JP2000500318A5 (ja)